Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 19, 2024 - Issue
Submit an article Journal homepage
0
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Bronchial Rheoplasty for Chronic Bronchitis: Results from a Canadian Feasibility Study with RheOx®

Marc Fortin1 Department of Pulmonary Medicine and Thoracic Surgery, University of Laval Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec, CanadaCorrespondence[email protected]
,
Del R Dorscheid2 Department of Medicine, St. Paul’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
,
Moishe Liberman3 Division of Thoracic Surgery, Centre hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada
,
Simon Martel1 Department of Pulmonary Medicine and Thoracic Surgery, University of Laval Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec, Canada
&
Tawimas Shaipanich2 Department of Medicine, St. Paul’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Pages 1673-1680 | Received 27 Mar 2024, Accepted 07 Jul 2024, Published online: 23 Jul 2024

References

  • Lowe KE, Regan EA, Anzueto A, et al. COPDGene® 2019: redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis Miami Fla. 2019;6(5):384–399. doi:10.15326/jcopdf.6.5.2019.0149
  • GOLD Report. Global initiative for chronic obstructive lung disease – GOLD; 2023. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed March 15, 2023.
  • Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen city heart study group. Am J Respir Crit Care Med. 1996;153(5):1530–1535. doi:10.1164/ajrccm.153.5.8630597
  • Pelkonen M, Notkola IL, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest. 2006;130(4):1129–1137. doi:10.1378/chest.130.4.1129
  • Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax. 2009;64(10):894–900. doi:10.1136/thx.2008.110619
  • Chai CS, Liam CK, Pang YK, et al. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2019;14:565–573. doi:10.2147/COPD.S196109
  • Global Initiative for Chronic Obstructive Lung Disease, Inc. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report); 2020. Available from: https://goldcopd.org/gold-reports/. Accessed February 17, 2021.
  • Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(3):228–237. doi:10.1164/rccm.201210-1843CI
  • Saetta M, Turato G, Baraldo S, et al. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med. 2000;161(3):1016–1021. doi:10.1164/ajrccm.161.3.9907080
  • Marchetti N, Duffy S, Criner GJ. Interventional bronchoscopic therapies for chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):547–557. doi:10.1016/j.ccm.2020.06.010
  • Hartman JE, Garner JL, Shah PL, Slebos DJ. New bronchoscopic treatment modalities for patients with chronic bronchitis. Eur Respir Rev Off J Eur Respir Soc. 2021;30(159). doi:10.1183/16000617.0281-2020
  • Valipour A, Fernandez-Bussy S, Ing AJ, et al. Bronchial rheoplasty for treatment of chronic bronchitis. Twelve-month results from a multicenter clinical trial. Am J Respir Crit Care Med. 2020;202(5):681–689. doi:10.1164/rccm.201908-1546OC
  • Krimsky W, Neal IIRE, Kim V. Airway mucosal remodeling: mechanism of action and preclinical data of pulsed electric fields for chronic bronchitis and mucus hypersecretion. Respir Int Rev Thorac Dis. 2023;1–13. doi:10.1159/000534370
  • Wells JM, Arenberg DA, Barjaktarevic I, et al. Safety and tolerability of comprehensive research bronchoscopy in chronic obstructive pulmonary disease. Results from the SPIROMICS bronchoscopy substudy. Ann Am Thorac Soc. 2019;16(4):439–446. doi:10.1513/AnnalsATS.201807-441OC
  • Jones PWS. George’s Respiratory Questionnaire: MCID. COPD J Chronic Obstr Pulm Dis. 2005;2(1):75–79. doi:10.1081/COPD-200050513
  • Verma A, Asivatham SJ, Deneke T, Castellvi Q, Neal RE. Primer on pulsed electrical field ablation: understanding the benefits and limitations. Circ Arrhythm Electrophysiol. 2021;14(9):e010086. doi:10.1161/CIRCEP.121.010086

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.